Skip to main content Skip to navigation
Recombinant Human IL-1β

Recombinant Human IL-1β

(RUO)
Product Details
Down Arrow Up Arrow


Description

Interleukin-1β (IL-1β) is a potent immunomodulator which mediates a wide range of immune and inflammatory responses including the activation of B and T cells. This is the mature form of human IL-1β, a 17 kD protein containing 153 amino acid residues, representing amino acids A117 through S269 of the IL-1β precursor protein, expressed in E. coli.  Recombinant human IL-1β (Cat. No. 554602) is lyophilized from a solution comprised of 0.22 μm sterile-filtered aqueous buffered solution with no preservatives.  Recombinant human IL-1β is ≥ 95% pure as determined by SDS-PAGE, and an absorbance assay based on the Beers-Lambert law. The endotoxin level is ≤ 1.0 EU per µg of human IL-1β as measured in a chromogenic LAL assay.



Preparation And Storage

Store product at -80°C prior to use or for long term storage of stock solutions. This preparation contains no preservatives, thus it should be handled under aseptic conditions.

Recommended Assay Procedures

Recombinant human IL-1β (Cat. No. 554602) may be reconstituted in sterile neutral buffer containing 0.5 - 10 mg/mL carrier protein, such as human or bovine serum albumin, aliquoted and stored at –   80°C.  For in vitro biological assay use, carrier-protein concentrations of 0.5 - 1 mg/mL are recommended.  For use as an ELISA standard, carrier-protein concentrations of 5 - 10 mg/mL are recommended.  Failure to add carrier protein or store at indicated temperatures may result in a loss of activity.  Carrier proteins should be pre-screened for possible effects in each investigator's experimental system.  Carrier proteins may have an undesired influence on experimental results due to toxicity, high endotoxin levels or possible blocking activity.

Bioassay:  Investigators are advised that the Bioassay application is not routinely tested for this material and are highly encouraged to both titrate this material and include appropriate controls in relevant experiments.  An activity range of 1.0 - 4.0 x 10^8 units/mg, encompassing an

ED50= 25 - 100 pg/mL, has previously been reported using TF-1 as indicator cells for proliferaiton, with a unit defined as  the amount of material needed to stimulate a half-maximal response at cytokine saturation.

Product Notices

  1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
  2. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
  3. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
554602 Rev. 2
Citations & References
Down Arrow Up Arrow

Development References (4)

  1. Auron PE, Webb AC, Rosenwasser LJ, et al. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci U S A. 1984; 81(24):7907-7911. (Biology). View Reference
  2. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991; 77(8):1627-1652. (Biology). View Reference
  3. Kitamura T, Takaku F, Miyajima A. IL-1 up-regulates the expression of cytokine receptors on a factor-dependent human hemopoietic cell line, TF-1. Int Immunol. 1991; 3(6):571-577. (Methodology). View Reference
  4. Kitamura T, Tange T, Terasawa T, et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol. 1989; 140(2):323-334. (Methodology). View Reference
View All (4) View Less
554602 Rev. 2

Please refer to Support Documents for Quality Certificates

Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described

Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims.  Comparisons are not made against non-BD technologies, unless otherwise noted.

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Refer to manufacturer's instructions for use and related User Manuals and Technical Data Sheets before using this product as described.

Comparisons, where applicable, are made against older BD technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.